Skills |
Ordering appropriate initial and, if indicated, next round ancillary studies based on clinical setting and differential diagnosis. Integrating ancillary studies including immunohistochemistry, flow cytometry immunophenotyping, cytogenetics, fluorescence in situ hybridization, targeted molecular studies
|
|
|
|
|
Knowledge areas |
Pathogenesis, clinical correlation, and prognostic significance; diagnostic and relevant clinical practice guidelines for hematolymphoid neoplasia, congenital, infectious, and other specific nonneoplastic entities
|
Flow cytometry immunophenotyping panels, immunohistochemical stains, cytogenetic analysis, including karyotyping and fluorescence in situ hybridization and molecular ancillary testing
|
Indications for and interpretation of next-generation sequencing panel testing, fluorescence in situ hybridization testing, and esoteric/sendout testing; techniques and technical limitations of ancillary studies
|
Example scenarios |
Perform complete diagnostic workup of myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, T/NK cell lymphomas, gray zone lymphomas, histiocytic and dendritic cell neoplasms, and nodular lymphocyte predominant Hodgkin lymphoma
|
ACGME Hematopathology Milestones version 2.0 |
|
Medical Knowledge 4, 5 and 6 (levels 3-5): Morphologic interpretation and diagnosis, selection of molecular and cytogenetics testing and interpretation of reports, clinical reasoning in hematopathology and hematology
|
|
|
Professionalism 1, 2, and 3: Professional behavior and ethical principles, accountability and conscientiousness, self-awareness and help-seeking
|
|